CAS 5630-53-5
:Tibolone
- (7A,17A)-17-Hydroxy-7-Methyl-19-Norpregn-5(10)-En-20-Yl-3-One
- (7Alpha,17Beta)-17-Ethynyl-17-Hydroxy-7-Methylestr-5(10)-En-3-One
- (7Alpha,8Xi,13Xi,17Beta)-17-Ethynyl-17-Hydroxy-7-Methylestr-5(10)-En-3-One
- (7α,17α)-17-Hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one
- 17-Hydroxy-7Alpha-Methyl-19-Norpregn-5(10)-En-20-Yn-3-One
- 17Alpha-Hydroxy-7Alpha-Methyl-19-Norpregn-5(10)-En-20-Yn-3-One
- 19-Nor-17α-pregn-5(10)-en-20-yn-3-one, 17-hydroxy-7α-methyl-
- 19-Norpregn-5(10)-En-20-Yn-3-One,17-Hydroxy-7-Methyl-, (7A,17A)-
- 5(10)-Estren-7-Alpha-Methyl-17-Alpha-Ethynyl-17-Beta-Ol-3-One
- 7α-Methyl-17α-ethynyl-17β-hydroxy-5(10)-estren-3-one
- 7α-Methyl-Δ<sup>5</sup>,<sup>10</sup>-norethindrone
- Livial
- Liviella
- Org OD 14
- Voir plus de synonymes
TIBOLONE FOR SYSTEM SUITABILITY CRS
CAS :TIBOLONE FOR SYSTEM SUITABILITY CRSFormule :C21H28O2Couleur et forme :Crystalline Powder. White. Crystals. Powder.Masse moléculaire :312.4458Tibolone
CAS :TiboloneFormule :C21H28O2Degré de pureté :99.5%Couleur et forme :WhiteMasse moléculaire :312.20893Tibolone
CAS :Tibolone is an estrogen-like compound used for the treatment of the symptoms associated with menopausal transition (i.e., climacteric symptoms) and also for theFormule :C21H28O2Degré de pureté :99.70% - 99.71%Couleur et forme :White To Off-White Crystalline PowderMasse moléculaire :312.45Tibolone
CAS :Produit contrôléApplications A synthetic steroid with weak estrogenic, androgenic and progestogenic activity. A pharamceutical used in the treatment of menopausal syndrome.
References de Visser, J., et al.: Arzneim.-Forsch., 34, 1010 (1984), Geusens, P., et al.: Maturitas Suppl, 1, 1 (1987)Formule :C21H28O2Couleur et forme :WhiteMasse moléculaire :312.45Tibolone
CAS :Produit contrôléTibolone is a synthetic steroidal estrogen with both estrogenic and progestogenic activity. It has been shown to be effective in the treatment of postmenopausal symptoms, especially those related to the breast. Tibolone is also used for prevention of osteoporosis and to prevent recurrence of hormone-dependent cancers such as breast cancer or endometrial cancer. Tibolone binds to both estrogen receptor subtypes (ERα and ERβ) and progesterone receptor (PR), but with higher affinity for ERβ. This leads to increased levels of circulating estradiol and progesterone when compared to other estrogens such as nomegestrol acetate or conjugated equine estrogen. The drug also decreases expression of genes that are regulated by the response element (RE) in ERβ-positive cells, which may contribute to its anti-cancer effects. Tibolone has been shown to be statistically more effective than nomegestrol acetate in reducing hot flashes
Formule :C21H28O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :312.45 g/molTibolone (1 mg/ml in Acetonitrile)
CAS :Produit contrôléFormule :C21H28O2Couleur et forme :Single SolutionMasse moléculaire :312.45








